key: cord-1018247-5st51482
authors: Hubert, Florent; Chessa, Céline; Beby‐Defaux, Agnès; Bourgoin, Anne; Boinot, Laurence; Noury, Ursula; Lariviere, Andy; Benlaassri, Mohammed; Garcia, Magali; Leveque, Nicolas
title: Emergence of the SARS‐CoV‐2 B.1.1.7 variant observed at the Poitiers University Hospital
date: 2021-05-24
journal: J Med Virol
DOI: 10.1002/jmv.27092
sha: 141152f62c64e059f0148dafdf77d7da686dd029
doc_id: 1018247
cord_uid: 5st51482

SARS-CoV-2 is responsible for the highly spreading coronavirus disease 2019 (COVID-19). Currently (May 11, 2021), the total number of confirmed COVID-19 cases has reached more than 159 million This article is protected by copyright. All rights reserved.

September 20, 2020, in the London area. During the third week of December (from the 14th to the 20th), it already represented half of the total SARS-CoV-2 strains sequenced in the UK. Two weeks later, from December 28, it reached more than 70%. 3 The amino acid change N501Y has been suggested as increasing the binding affinity of the virus to its receptor, the human ACE2. 4 Davies et al. 5 estimated that the B.1.1.7 variant is 56% more transmissible (95% confidence interval [CI] 50%-74%) than previously identified SARS-CoV-2 variants. In addition, the same authors showed that B.1.1.7 infection was associated with 55% (95% CI 39%-72%) higher mortality. 6 Concomitantly with the emergence of the B.1.1.7 variant, the UK experienced a new epidemic peak, with up to 50,000 new cases of SARS-CoV-2 infections per day at the beginning of January 2021. The number of deaths linked to COVID-19 has also increased, with an average of 1300 deaths per day at the end of January. 7 The laboratory of virology of the Poitiers University Hospital 10 The consequences on the number of hospitalized patients are not yet certain, particularly regarding hospitalizations in intensive care, but they will need to be closely monitored over the weeks to come. Likewise, the impact of vaccination deployment on the evolution of the circulation of this highly contagious variant will constitute a valuable predictive indicator of the evolution of the pandemic over the months to come.

All the authors declare that there are no conflict of interests. 

COVID-19) Dashboard

Emergence of a new SARS-CoV-2 variant in the UK

COVID-19 Genomics UK Consortium | UK-Wide Genomic Sequencing

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 12/ 01 in England

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Investigation of Novel SARS-CoV-2 Variant -Technical Briefing 5

Données Hospitalières Relatives à l'épidémie de COVID-19: data.gouv.fr

Transmission of SARS-CoV-2 lineage B.1.1.7 in England: insights from linking epidemiological and genetic data